CVE-2026-34324: Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences InForm. Successful attacks of this vulnerability can result in unauthorized update, insert or delete access to some of Oracle Life Sciences InForm accessible data as well as unauthorized read access to a subset of Oracle Life Sciences InForm accessible data. in Oracle Corporation Oracle Life Sciences InForm
Vulnerability in the Oracle Life Sciences InForm product of Oracle Life Science Applications (component: App Server). Supported versions that are affected are 7.0.1.0 and 7.0.1.1. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences InForm. Successful attacks of this vulnerability can result in unauthorized update, insert or delete access to some of Oracle Life Sciences InForm accessible data as well as unauthorized read access to a subset of Oracle Life Sciences InForm accessible data. CVSS 3.1 Base Score 6.5 (Confidentiality and Integrity impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N).
AI Analysis
Technical Summary
This vulnerability affects the Oracle Life Sciences InForm product, specifically versions 7.0.1.0 and 7.0.1.1, within the application server component. It allows an unauthenticated attacker with network access over HTTP to compromise the system by gaining unauthorized ability to update, insert, or delete some accessible data, as well as read unauthorized subsets of data. The CVSS 3.1 vector indicates network attack vector, low attack complexity, no privileges required, no user interaction, unchanged scope, with low confidentiality and integrity impacts and no availability impact. The vulnerability is considered easily exploitable. Oracle’s April 2026 Critical Patch Update advisory references multiple patches across products but does not explicitly confirm a patch for this vulnerability in the provided text. Customers are advised to apply Critical Patch Updates promptly to address known vulnerabilities.
Potential Impact
Successful exploitation can lead to unauthorized read access to some data and unauthorized modification (update, insert, delete) of some accessible data within Oracle Life Sciences InForm. This compromises confidentiality and integrity of the affected data but does not impact system availability. The vulnerability requires only network access via HTTP and no authentication, increasing risk if the system is exposed to untrusted networks. No known active exploitation has been reported.
Mitigation Recommendations
Oracle’s April 2026 Critical Patch Update advisory recommends applying the latest patches promptly. Although the advisory does not explicitly confirm a patch for CVE-2026-34324, it strongly encourages customers to remain on actively supported versions and apply Critical Patch Updates without delay to mitigate this and other vulnerabilities. Patch status for this specific vulnerability is not explicitly confirmed in the advisory; therefore, users should consult the vendor advisory directly for the most current remediation information. No vendor statement indicates that no action is required or that the vulnerability is already mitigated.
CVE-2026-34324: Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences InForm. Successful attacks of this vulnerability can result in unauthorized update, insert or delete access to some of Oracle Life Sciences InForm accessible data as well as unauthorized read access to a subset of Oracle Life Sciences InForm accessible data. in Oracle Corporation Oracle Life Sciences InForm
Description
Vulnerability in the Oracle Life Sciences InForm product of Oracle Life Science Applications (component: App Server). Supported versions that are affected are 7.0.1.0 and 7.0.1.1. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences InForm. Successful attacks of this vulnerability can result in unauthorized update, insert or delete access to some of Oracle Life Sciences InForm accessible data as well as unauthorized read access to a subset of Oracle Life Sciences InForm accessible data. CVSS 3.1 Base Score 6.5 (Confidentiality and Integrity impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N).
AI-Powered Analysis
Machine-generated threat intelligence
Technical Analysis
This vulnerability affects the Oracle Life Sciences InForm product, specifically versions 7.0.1.0 and 7.0.1.1, within the application server component. It allows an unauthenticated attacker with network access over HTTP to compromise the system by gaining unauthorized ability to update, insert, or delete some accessible data, as well as read unauthorized subsets of data. The CVSS 3.1 vector indicates network attack vector, low attack complexity, no privileges required, no user interaction, unchanged scope, with low confidentiality and integrity impacts and no availability impact. The vulnerability is considered easily exploitable. Oracle’s April 2026 Critical Patch Update advisory references multiple patches across products but does not explicitly confirm a patch for this vulnerability in the provided text. Customers are advised to apply Critical Patch Updates promptly to address known vulnerabilities.
Potential Impact
Successful exploitation can lead to unauthorized read access to some data and unauthorized modification (update, insert, delete) of some accessible data within Oracle Life Sciences InForm. This compromises confidentiality and integrity of the affected data but does not impact system availability. The vulnerability requires only network access via HTTP and no authentication, increasing risk if the system is exposed to untrusted networks. No known active exploitation has been reported.
Mitigation Recommendations
Oracle’s April 2026 Critical Patch Update advisory recommends applying the latest patches promptly. Although the advisory does not explicitly confirm a patch for CVE-2026-34324, it strongly encourages customers to remain on actively supported versions and apply Critical Patch Updates without delay to mitigate this and other vulnerabilities. Patch status for this specific vulnerability is not explicitly confirmed in the advisory; therefore, users should consult the vendor advisory directly for the most current remediation information. No vendor statement indicates that no action is required or that the vulnerability is already mitigated.
Technical Details
- Data Version
- 5.2
- Assigner Short Name
- oracle
- Date Reserved
- 2026-03-26T19:48:45.682Z
- Cvss Version
- 3.1
- State
- PUBLISHED
- Remediation Level
- null
- Vendor Advisory Urls
- [{"url":"https://www.oracle.com/security-alerts/cpuapr2026.html","vendor":"Oracle"}]
Threat ID: 69e7e5ad19fe3cd2cdfa00c4
Added to database: 4/21/2026, 9:01:33 PM
Last enriched: 4/21/2026, 9:32:43 PM
Last updated: 4/22/2026, 7:35:05 AM
Views: 8
Community Reviews
0 reviewsCrowdsource mitigation strategies, share intel context, and vote on the most helpful responses. Sign in to add your voice and help keep defenders ahead.
Want to contribute mitigation steps or threat intel context? Sign in or create an account to join the community discussion.
Actions
Updates to AI analysis require Pro Console access. Upgrade inside Console → Billing.
External Links
Need more coverage?
Upgrade to Pro Console for AI refresh and higher limits.
For incident response and remediation, OffSeq services can help resolve threats faster.
Latest Threats
Check if your credentials are on the dark web
Instant breach scanning across billions of leaked records. Free tier available.